Skip to content

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07435168
Acronym
CHEST-CA
Enrollment
300
Registered
2026-02-27
Start date
2024-04-01
Completion date
2027-04-01
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Amyloidosis, Chest Pain

Brief summary

The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD). Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD. Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.

Interventions

OTHERScreening thourgh examinations including bonescintigraphy

Clinical examination, blood samples, echo, bone scintigraphy

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

No signs of CAD through Rb-PET and/or CT coronary arteriogram

Exclusion criteria

Previous history of amyloidosis

Design outcomes

Primary

MeasureTime frame
Prevalence of ATTR-CA in patients experiencing chest painUp to 4 weeks

Countries

Denmark

Contacts

CONTACTNavid Noory, MD
navid.noory@regionh.dk4535453108

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026